↓ Skip to main content

Low dose naltrexone for induction of remission in Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy
1 policy source
twitter
23 tweeters
facebook
4 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Low dose naltrexone for induction of remission in Crohn's disease
Published in
Cochrane database of systematic reviews, February 2014
DOI 10.1002/14651858.cd010410.pub2
Pubmed ID
Authors

Dan Segal, John K MacDonald, Nilesh Chande

Abstract

Crohn's disease is a transmural, relapsing inflammatory condition afflicting the digestive tract. Opioid signalling, long known to affect secretion and motility in the gut, has been implicated in the inflammatory cascade of Crohn's disease. Low dose naltrexone, an opioid antagonist, has garnered interest as a potential therapy.

Twitter Demographics

The data shown below were collected from the profiles of 23 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 15%
Student > Postgraduate 2 15%
Student > Master 1 8%
Other 1 8%
Student > Ph. D. Student 1 8%
Other 1 8%
Unknown 5 38%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 15%
Unspecified 2 15%
Medicine and Dentistry 2 15%
Nursing and Health Professions 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Other 0 0%
Unknown 5 38%

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2017.
All research outputs
#756,539
of 13,415,366 outputs
Outputs from Cochrane database of systematic reviews
#2,435
of 10,587 outputs
Outputs of similar age
#12,793
of 187,727 outputs
Outputs of similar age from Cochrane database of systematic reviews
#56
of 208 outputs
Altmetric has tracked 13,415,366 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,587 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,727 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 208 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.